Login
Boehringer Ingelheim
  • Therapeutic Area
    • Metabolic
    • Cardiovascular
      SPAF RWE Data Visualization Tool
    • Oncology
    • Respiratory
    • Inflammation
  • Products
    All products
    • Metabolic
      EmpagliflozinLinagliptin
    • Cardiovascular
      Dabigatran etexilateTelmisartan
    • Oncology
      Afatinib
    • Respiratory
      Tiotropium + Olodaterol
    • Inflammation
      Nintedanib
  • Resources
  • Podcasts
  • Contact
Login
  • PTP videos
  • Heart Failure Got Treatment
    Heart Failure Got Treatment
    • HFGT||What do you look forward the most with the latest indication of Jardiance?
    • HFGT||What is the Biggest Unmet Need in HF Treatment?
    • HFGT||How do you recognise a HF patient?
    • HFGT||How does Jardiance change the way physician treat HF?
    • HFGT||What is the value of Jardiance in HF treatment?
    • HFGT||Are the Benefits of Jardiance similar in both HFrEF and HFpEF treatment?
    • HFGT||How does Jardiance simplify HF treatment?
    • HFGT||What benefits would Jardiance provide to your patients?
    • HFGT||What is doctor’s experience on Jardiance safety profile?
    • HFGT||Cardiac Remodeling
    • HFGT||Early Benefits
    • HFGT||Start Jardiance Early, But When?
  • Let's Talk
    Let's Talk
    • PTPHF||Guidelines recommend the 4-pillar approach in managing HFrEF. What is a practical approach to implement this?
    • PTPHF||How has the HFpEF guidelines evolved with the advent of SGLT2i trials?
    • PTPHF||What is the impact of SGLT-2i trials in HFpEF?
    • PTPHF||What is the impact on the treatment landscape from the early benefits seen in the EMPEROR trials?
    • PTPHF||What do we know about the consistency of the results for empagliflozin across the spectrum of ejection fraction?
    • PTPHF||What is the role of empagliflozin in patients hospitalized for heart failure?
    • PTPHF||What makes SGLT2i an ideal HF therapy?
    • PTPHF||What are the kidney benefits that empagliflozin can offer to heart failure patients?
  • Prescribing Information
    Prescribing Information
    • Jardiance® Prescribing Information
    • Empagliflozin Metformin HCI (Jardiance Duo®) Prescribing Information

Close ×
  • Therapeutic Area
  • Metabolic
  • Cardiovascular
  • Oncology
  • Respiratory
  • Inflammation
  • Flipbook
  • Resources
  • Videos
  • Clinical studies
  • Site map
  • Terms of use
  • Privacy
  • Contact
  • Change country

Copyright © 2025 Boehringer Ingelheim (Malaysia) Sdn Bhd.
All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement.

This website is intended for healthcare professionals in Malaysia. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.